THRD Live signaler | Maksimer profitt med Getagraph.com

KJøP 122665 min ago

@ $9.00

Utstedt: 13 feb 2024 @ 18:30

Avkastning: 31.00%

Forrige signal: feb 6 - 19:49

Forrige signal: Selg

Avkastning: -2.39 %

Live Chart Being Loaded With Signals

Commentary (8 mai 2024 @ 22:00):

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...

Stats
Dagens volum	101 240
Gjennomsnittsvolum	154 701
Markedsverdi	480.52M
EPS	$-0.190 ( 2023-11-09 )
Neste inntjeningsdato	( $-0.330 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.12
ATR14	$0.0300 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Holles Natalie C.	Buy	13 558	Common Stock
2024-04-11	Holles Natalie C.	Sell	13 558	Common Stock
2024-04-11	Holles Natalie C.	Sell	13 558	Employee Stock Option (right to buy)
2024-04-04	Person Julie	Sell	1 107	Employee Option Grant (right to buy)
2024-04-04	Person Julie	Buy	1 107	Common Stock

INSIDER POWER
5.84
Last 98 transactions
Buy: 24 902 019 \| Sell: 27 277 881

Volum Korrelasjon

Lang: 0.05 (neutral)

Kort: -0.61 (weak negative)

Signal:(57.191) Neutral

Third Harmonic Bio, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Third Harmonic Bio, Inc. Korrelasjon - Valuta/Råvare

-0.01
( neutral )

0.38
( neutral )

0.00
( neutral )

0.42
( neutral )

0.24
( neutral )

-0.42
( neutral )

Third Harmonic Bio, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2023
Omsetning:	$0
Bruttogevinst:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2022
Omsetning:	$0
Bruttogevinst:	$-38 000.00 (0.00 %)
EPS:	$-0.960

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.730

Financial Reports:

No articles found.

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Sanntidsoppdatering for Third Harmonic Bio, Inc. [THRD]

Upcoming Earnings Alert